HOME › DRUGS › CYTARABINE
ACTIVE SUBSTANCE / INN

CYTARABINE

Brand name(s): VYXEOS, CYTOSAR-U, DEPOCYT, CYTARABINE, DepoCyte
FDA LISTED
EMA LISTED
PRESCRIPTION
WITHDRAWN
DISCONTINUED
ANDA075206
NDA021041
ACTIVE SUBSTANCE
Cytarabine
REGULATORS
FDA · EMA
SPONSORS / MAH
PACIRA PHARMS INC, Pacira Limited, JAZZ PHARMS THERAP
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
CYTARABINEANDA211938GLANDPrescription
CYTARABINEANDA206189MEITHEALDiscontinued
DEPOCYTNDA021041PACIRA PHARMS INCDiscontinued
CYTOSAR-UANDA075206TEVA PHARMS USADiscontinued
VYXEOSNDA209401JAZZ PHARMS THERAPPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
DepoCytePacira LimitedWithdrawn11/07/2001Meningeal Neoplasms

FULL INTELLIGENCE ON CYTARABINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →